Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Grifols, S.A.

GIFOFPNK
Healthcare
Drug Manufacturers - General
$8.85
$0.00(0.00%)
U.S. Market opens in 8h 25m

Grifols, S.A. (GIFOF) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.7B
P/E Ratio13.70
EPS (TTM)$0.64
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$10.08
3 Months$10.01
1 Year Target$9.23

GIFOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GIFOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.70 and a market capitalization of 8.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.45%
3-Month Change
0.45%
6-Month Change
0.45%
Year-to-Date (YTD) Change
0.45%
1-Year Change
19.27%
3-Year Change
-3.28%
5-Year Change
-44.86%
All-Time (Max) Change
-66.35%

Contact Information

34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

238,330 Employees
IPO DateFeb 6, 2013
CountryES
Actively Trading

Frequently Asked Questions